Pharmafile Logo
Pharmafocus logo
Advanced Search

HGS

Showing 6 posts of 6 posts found.

capture

HGS founders join IMS Health team

October 23, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HGS, IMS Health, mcfarlane

Healthcare services firm IMS Health has appointed HGS Europe founders Graeme McFarlane and Angela McFarlane (pictured) to its UK team. 

Appointment
human genome sciences

HGS shareholder challenges ‘poison pill’

May 31, 2012
Sales and Marketing Benlysta, GSK, HGS, hostile bid

The saga of GlaxoSmithKline’s attempt to take over Human Genome Sciences (HGS) has taken another turn with legal action by …

News
GSK

Rumours abound on GSK-HGS takeover bid

October 20, 2011
Research and Development, Sales and Marketing Benlysta, GSK, HGS

Rumours are gathering pace that GlaxoSmithKline may launch a takeover bid for struggling US firm Human Genome Sciences. British tabloid …

News

Benlysta to be fast-tracked by FDA

August 20, 2010
Sales and Marketing Benlysta, GSK, HGS, Lupus

 New lupus drug Benlysta has been given priority review status by the FDA.Benlysta (belimumab) has been developed by Human Genome …

News

Secondary endpoints failure take shine off Benlysta

April 21, 2010
Sales and Marketing GSK, HGS, Lupus

GlaxoSmithKline’s lupus treatment has failed to reach a statistically significant secondary endpoint in the second of two phase III trials. …

News

Lupus drug shows surprise phase III success

July 23, 2009
Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025